These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 16170757
1. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M, Adult AIDS Clinical Trials Group 746 Substudy Team. J Infect Dis; 2005 Oct 15; 192(8):1398-406. PubMed ID: 16170757 [Abstract] [Full Text] [Related]
5. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. Lima VD, Harrigan R, Murray M, Moore DM, Wood E, Hogg RS, Montaner JS. AIDS; 2008 Nov 12; 22(17):2371-80. PubMed ID: 18981777 [Abstract] [Full Text] [Related]
6. Efficacy and safety of atazanavir-based highly active antiretroviral therapy in patients with virologic suppression switched from a stable, boosted or unboosted protease inhibitor treatment regimen: the SWAN Study (AI424-097) 48-week results. Gatell J, Salmon-Ceron D, Lazzarin A, Van Wijngaerden E, Antunes F, Leen C, Horban A, Wirtz V, Odeshoo L, Van den Dungen M, Gruber C, Ledesma E, SWAN Study Group. Clin Infect Dis; 2007 Jun 01; 44(11):1484-92. PubMed ID: 17479947 [Abstract] [Full Text] [Related]
7. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Clin Infect Dis; 2001 Sep 01; 33(5):700-5. PubMed ID: 11486292 [Abstract] [Full Text] [Related]
9. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy. Moore DM, Hogg RS, Yip B, Wood E, Harris M, Montaner JS. HIV Med; 2006 Jul 01; 7(5):311-6. PubMed ID: 16945076 [Abstract] [Full Text] [Related]
10. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC. Clin Infect Dis; 2006 Jan 15; 42(2):252-9. PubMed ID: 16355337 [Abstract] [Full Text] [Related]
19. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen. Gandhi T, Nagappan V, Cinti S, Wei W, Kazanjian P. Clin Infect Dis; 2007 Oct 15; 45(8):1085-92. PubMed ID: 17879930 [Abstract] [Full Text] [Related]